Global Medical Morphine Market Growth 2025-2031

October 2025 | 99 pages | ID: G1FCD52F5C9AEN
LP Information

Abstracts

The global Medical Morphine market size is predicted to grow from US$ 11460 million in 2025 to US$ 13220 million in 2031; it is expected to grow at a CAGR of 2.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3–7 hours. Long-acting formulations also exist.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the “Medical Morphine Industry Forecast” looks at past sales and reviews total world Medical Morphine sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Morphine sales for 2025 through 2031. With Medical Morphine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Morphine industry.

This Insight Report provides a comprehensive analysis of the global Medical Morphine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Morphine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Morphine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Morphine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Morphine.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Morphine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Oral
• Injectables

Segmentation by Application:

• Cancer
• Arthritis

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Mallinckrodt Pharmaceuticals
• Alcaliber
• Purdue Pharma
• Pfizer
• Sun Pharmaceutical Industries
• Taj Pharmaceuticals Limited

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Morphine market?
What factors are driving Medical Morphine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Morphine market opportunities vary by end market size?
How does Medical Morphine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Amorolfine Market Size (2020-2031)
  2.1.2 Amorolfine Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Amorolfine by Country/Region (2020, 2024 & 2031)
2.2 Amorolfine Segment by Type
  2.2.1 Purity:?99%
  2.2.2 Purity:?99%
2.3 Amorolfine Market Size by Type
  2.3.1 Amorolfine Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Amorolfine Market Size Market Share by Type (2020-2025)
2.4 Amorolfine Segment by Application
  2.4.1 Injection Product
  2.4.2 Table Product
  2.4.3 Others
2.5 Amorolfine Market Size by Application
  2.5.1 Amorolfine Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Amorolfine Market Size Market Share by Application (2020-2025)

3 AMOROLFINE MARKET SIZE BY PLAYER

3.1 Amorolfine Market Size Market Share by Player
  3.1.1 Global Amorolfine Revenue by Player (2020-2025)
  3.1.2 Global Amorolfine Revenue Market Share by Player (2020-2025)
3.2 Global Amorolfine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 AMOROLFINE BY REGION

4.1 Amorolfine Market Size by Region (2020-2025)
4.2 Global Amorolfine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Amorolfine Market Size Growth (2020-2025)
4.4 APAC Amorolfine Market Size Growth (2020-2025)
4.5 Europe Amorolfine Market Size Growth (2020-2025)
4.6 Middle East & Africa Amorolfine Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Amorolfine Market Size by Country (2020-2025)
5.2 Americas Amorolfine Market Size by Type (2020-2025)
5.3 Americas Amorolfine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Amorolfine Market Size by Region (2020-2025)
6.2 APAC Amorolfine Market Size by Type (2020-2025)
6.3 APAC Amorolfine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Amorolfine Market Size by Country (2020-2025)
7.2 Europe Amorolfine Market Size by Type (2020-2025)
7.3 Europe Amorolfine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Amorolfine by Region (2020-2025)
8.2 Middle East & Africa Amorolfine Market Size by Type (2020-2025)
8.3 Middle East & Africa Amorolfine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL AMOROLFINE MARKET FORECAST

10.1 Global Amorolfine Forecast by Region (2026-2031)
  10.1.1 Global Amorolfine Forecast by Region (2026-2031)
  10.1.2 Americas Amorolfine Forecast
  10.1.3 APAC Amorolfine Forecast
  10.1.4 Europe Amorolfine Forecast
  10.1.5 Middle East & Africa Amorolfine Forecast
10.2 Americas Amorolfine Forecast by Country (2026-2031)
  10.2.1 United States Market Amorolfine Forecast
  10.2.2 Canada Market Amorolfine Forecast
  10.2.3 Mexico Market Amorolfine Forecast
  10.2.4 Brazil Market Amorolfine Forecast
10.3 APAC Amorolfine Forecast by Region (2026-2031)
  10.3.1 China Amorolfine Market Forecast
  10.3.2 Japan Market Amorolfine Forecast
  10.3.3 Korea Market Amorolfine Forecast
  10.3.4 Southeast Asia Market Amorolfine Forecast
  10.3.5 India Market Amorolfine Forecast
  10.3.6 Australia Market Amorolfine Forecast
10.4 Europe Amorolfine Forecast by Country (2026-2031)
  10.4.1 Germany Market Amorolfine Forecast
  10.4.2 France Market Amorolfine Forecast
  10.4.3 UK Market Amorolfine Forecast
  10.4.4 Italy Market Amorolfine Forecast
  10.4.5 Russia Market Amorolfine Forecast
10.5 Middle East & Africa Amorolfine Forecast by Region (2026-2031)
  10.5.1 Egypt Market Amorolfine Forecast
  10.5.2 South Africa Market Amorolfine Forecast
  10.5.3 Israel Market Amorolfine Forecast
  10.5.4 Turkey Market Amorolfine Forecast
10.6 Global Amorolfine Forecast by Type (2026-2031)
10.7 Global Amorolfine Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Amorolfine Forecast

11 KEY PLAYERS ANALYSIS

11.1 Nishchem International
  11.1.1 Nishchem International Company Information
  11.1.2 Nishchem International Amorolfine Product Offered
  11.1.3 Nishchem International Amorolfine Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Nishchem International Main Business Overview
  11.1.5 Nishchem International Latest Developments
11.2 Canagen Pharmaceuticals Inc
  11.2.1 Canagen Pharmaceuticals Inc Company Information
  11.2.2 Canagen Pharmaceuticals Inc Amorolfine Product Offered
  11.2.3 Canagen Pharmaceuticals Inc Amorolfine Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Canagen Pharmaceuticals Inc Main Business Overview
  11.2.5 Canagen Pharmaceuticals Inc Latest Developments
11.3 Allastir
  11.3.1 Allastir Company Information
  11.3.2 Allastir Amorolfine Product Offered
  11.3.3 Allastir Amorolfine Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Allastir Main Business Overview
  11.3.5 Allastir Latest Developments
11.4 Sun Pharma
  11.4.1 Sun Pharma Company Information
  11.4.2 Sun Pharma Amorolfine Product Offered
  11.4.3 Sun Pharma Amorolfine Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Sun Pharma Main Business Overview
  11.4.5 Sun Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Medical Morphine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Medical Morphine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectables
Table 5. Global Medical Morphine Sales by Type (2020-2025) & (K Units)
Table 6. Global Medical Morphine Sales Market Share by Type (2020-2025)
Table 7. Global Medical Morphine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Medical Morphine Revenue Market Share by Type (2020-2025)
Table 9. Global Medical Morphine Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Medical Morphine Sale by Application (2020-2025) & (K Units)
Table 11. Global Medical Morphine Sale Market Share by Application (2020-2025)
Table 12. Global Medical Morphine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Medical Morphine Revenue Market Share by Application (2020-2025)
Table 14. Global Medical Morphine Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Medical Morphine Sales by Company (2020-2025) & (K Units)
Table 16. Global Medical Morphine Sales Market Share by Company (2020-2025)
Table 17. Global Medical Morphine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Medical Morphine Revenue Market Share by Company (2020-2025)
Table 19. Global Medical Morphine Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Medical Morphine Producing Area Distribution and Sales Area
Table 21. Players Medical Morphine Products Offered
Table 22. Medical Morphine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Medical Morphine Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Medical Morphine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Medical Morphine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Medical Morphine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Medical Morphine Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Medical Morphine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Medical Morphine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Medical Morphine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Medical Morphine Sales by Country (2020-2025) & (K Units)
Table 34. Americas Medical Morphine Sales Market Share by Country (2020-2025)
Table 35. Americas Medical Morphine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Medical Morphine Sales by Type (2020-2025) & (K Units)
Table 37. Americas Medical Morphine Sales by Application (2020-2025) & (K Units)
Table 38. APAC Medical Morphine Sales by Region (2020-2025) & (K Units)
Table 39. APAC Medical Morphine Sales Market Share by Region (2020-2025)
Table 40. APAC Medical Morphine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Medical Morphine Sales by Type (2020-2025) & (K Units)
Table 42. APAC Medical Morphine Sales by Application (2020-2025) & (K Units)
Table 43. Europe Medical Morphine Sales by Country (2020-2025) & (K Units)
Table 44. Europe Medical Morphine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Medical Morphine Sales by Type (2020-2025) & (K Units)
Table 46. Europe Medical Morphine Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Medical Morphine Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Medical Morphine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Medical Morphine Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Medical Morphine Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Medical Morphine
Table 52. Key Market Challenges & Risks of Medical Morphine
Table 53. Key Industry Trends of Medical Morphine
Table 54. Medical Morphine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Medical Morphine Distributors List
Table 57. Medical Morphine Customer List
Table 58. Global Medical Morphine Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Medical Morphine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Medical Morphine Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Medical Morphine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Medical Morphine Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Medical Morphine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Medical Morphine Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Medical Morphine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Medical Morphine Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Medical Morphine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Medical Morphine Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Medical Morphine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Medical Morphine Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Medical Morphine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Mallinckrodt Pharmaceuticals Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 73. Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolios and Specifications
Table 74. Mallinckrodt Pharmaceuticals Medical Morphine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Mallinckrodt Pharmaceuticals Main Business
Table 76. Mallinckrodt Pharmaceuticals Latest Developments
Table 77. Alcaliber Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 78. Alcaliber Medical Morphine Product Portfolios and Specifications
Table 79. Alcaliber Medical Morphine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Alcaliber Main Business
Table 81. Alcaliber Latest Developments
Table 82. Purdue Pharma Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 83. Purdue Pharma Medical Morphine Product Portfolios and Specifications
Table 84. Purdue Pharma Medical Morphine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Purdue Pharma Main Business
Table 86. Purdue Pharma Latest Developments
Table 87. Pfizer Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Medical Morphine Product Portfolios and Specifications
Table 89. Pfizer Medical Morphine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Sun Pharmaceutical Industries Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sun Pharmaceutical Industries Medical Morphine Product Portfolios and Specifications
Table 94. Sun Pharmaceutical Industries Medical Morphine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Sun Pharmaceutical Industries Main Business
Table 96. Sun Pharmaceutical Industries Latest Developments
Table 97. Taj Pharmaceuticals Limited Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 98. Taj Pharmaceuticals Limited Medical Morphine Product Portfolios and Specifications
Table 99. Taj Pharmaceuticals Limited Medical Morphine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Taj Pharmaceuticals Limited Main Business
Table 101. Taj Pharmaceuticals Limited Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Medical Morphine
Figure 2. Medical Morphine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Morphine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Medical Morphine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Medical Morphine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Medical Morphine Sales Market Share by Country/Region (2024)
Figure 10. Medical Morphine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injectables
Figure 13. Global Medical Morphine Sales Market Share by Type in 2025
Figure 14. Global Medical Morphine Revenue Market Share by Type (2020-2025)
Figure 15. Medical Morphine Consumed in Cancer
Figure 16. Global Medical Morphine Market: Cancer (2020-2025) & (K Units)
Figure 17. Medical Morphine Consumed in Arthritis
Figure 18. Global Medical Morphine Market: Arthritis (2020-2025) & (K Units)
Figure 19. Global Medical Morphine Sale Market Share by Application (2024)
Figure 20. Global Medical Morphine Revenue Market Share by Application in 2025
Figure 21. Medical Morphine Sales by Company in 2025 (K Units)
Figure 22. Global Medical Morphine Sales Market Share by Company in 2025
Figure 23. Medical Morphine Revenue by Company in 2025 ($ millions)
Figure 24. Global Medical Morphine Revenue Market Share by Company in 2025
Figure 25. Global Medical Morphine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Medical Morphine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Medical Morphine Sales 2020-2025 (K Units)
Figure 28. Americas Medical Morphine Revenue 2020-2025 ($ millions)
Figure 29. APAC Medical Morphine Sales 2020-2025 (K Units)
Figure 30. APAC Medical Morphine Revenue 2020-2025 ($ millions)
Figure 31. Europe Medical Morphine Sales 2020-2025 (K Units)
Figure 32. Europe Medical Morphine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Medical Morphine Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Medical Morphine Revenue 2020-2025 ($ millions)
Figure 35. Americas Medical Morphine Sales Market Share by Country in 2025
Figure 36. Americas Medical Morphine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Medical Morphine Sales Market Share by Type (2020-2025)
Figure 38. Americas Medical Morphine Sales Market Share by Application (2020-2025)
Figure 39. United States Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Medical Morphine Sales Market Share by Region in 2025
Figure 44. APAC Medical Morphine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Medical Morphine Sales Market Share by Type (2020-2025)
Figure 46. APAC Medical Morphine Sales Market Share by Application (2020-2025)
Figure 47. China Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Medical Morphine Sales Market Share by Country in 2025
Figure 55. Europe Medical Morphine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Medical Morphine Sales Market Share by Type (2020-2025)
Figure 57. Europe Medical Morphine Sales Market Share by Application (2020-2025)
Figure 58. Germany Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 59. France Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Medical Morphine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Medical Morphine Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Medical Morphine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Medical Morphine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Medical Morphine in 2025
Figure 72. Manufacturing Process Analysis of Medical Morphine
Figure 73. Industry Chain Structure of Medical Morphine
Figure 74. Channels of Distribution
Figure 75. Global Medical Morphine Sales Market Forecast by Region (2026-2031)
Figure 76. Global Medical Morphine Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Medical Morphine Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Medical Morphine Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Medical Morphine Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Medical Morphine Revenue Market Share Forecast by Application (2026-2031)